Cannabix Technologies Inc. (BLOZF)
OTCMKTS · Delayed Price · Currency is USD
0.4156
-0.0055 (-1.30%)
Sep 2, 2025, 3:54 PM EDT
Cannabix Technologies Market Cap
Cannabix Technologies has a market cap or net worth of $50.92 million as of September 2, 2025. Its market cap has increased by 25.03% in one year.
Market Cap
50.92M
Enterprise Value
49.33M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.42
Market Cap Chart
Since December 18, 2013, Cannabix Technologies's market cap has increased from 540.03K to 50.92M, an increase of 9,329.97%. That is a compound annual growth rate of 47.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2025 | 50.92M | 98.86% |
| Dec 31, 2024 | 25.61M | 64.60% |
| Dec 29, 2023 | 15.56M | -43.24% |
| Dec 30, 2022 | 27.41M | -43.72% |
| Dec 31, 2021 | 48.71M | -34.40% |
| Dec 31, 2020 | 74.25M | 147.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 832.17M |
| Elite Pharmaceuticals | 734.61M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 655.63M |
| Northwest Biotherapeutics | 448.50M |
| CytoDyn | 376.00M |
| American Oncology Network | 343.87M |